Litcius/Paper detail

TERT promoter mutation status is necessary and sufficient to diagnose IDH-wildtype diffuse astrocytic glioma with molecular features of glioblastoma

Kenji Fujimoto, Hideyuki Arita, Kaishi Satomi, Kai Yamasaki, Yuko Matsushita, Taishi Nakamura, Yasuji Miyakita, Toru Umehara, Keiichi Kobayashi, Kaoru Tamura, Shota Tanaka, Fumi Higuchi, Yoshiko Okita, Yonehiro Kanemura, Junya Fukai, Daisuke Sakamoto, Takehiro Uda, Ryunosuke Machida, Aya Kuchiba, Taketoshi Maehara, Motoo Nagane, Ryo Nishikawa, Hiroyoshi Suzuki, Makoto Shibuya, Takashi Komori, Yoshitaka Narita, Koichi Ichimura

2021Acta Neuropathologica107 citationsDOI

Topics & Concepts

CDKN2APDGFRAPTENWild typeGliomaIDH1BiologyCancer researchOncologyInternal medicineMedicineMutationCancerMutantGeneticsStromal cellPI3K/AKT/mTOR pathwayGeneApoptosisGiSTGlioma Diagnosis and TreatmentHedgehog Signaling Pathway StudiesMicrotubule and mitosis dynamics
TERT promoter mutation status is necessary and sufficient to diagnose IDH-wildtype diffuse astrocytic glioma with molecular features of glioblastoma | Litcius